영문목차
Contents
Part I Pandemic Influenza Overview
Pandemic Influenza as a Current Threat 3
Antigenic Cross-Reactivity Among H5Nl Viruses 25
Part II Current Approaches for Human and Avian Vaccine Production
Seasonal Influenza Vaccines 43
Generation and Characterization of Candidate Vaccine Viruses for Prepandemic Influenza Vaccines 83
Live Attenuated Vaccines for Pandemic Influenza 109
Influenza Vaccines for Avian Species 133
Development and Application of Avian Influenza Vaccines in China 153
Part III Novel Vaccine Approaches
Designing Vaccines for Pandemic Influenza 165
Attenuated Influenza Virus Vaccines with Modified NS1 Proteins 177
DNA Vaccines Against Influenza Viruses 197
Recombinant Proteins Produced in Insect Cells 211
Influenza Neuraminidase as a Vaccine Antigen 227
Recombinant Vectors as Influenza Vaccines 243
Influenza Virus-Like Particles as Pandemic Vaccines 269
Pandemic Influenza Vaccines 291
Adjuvants for Pandemic Influenza Vaccines 323
Part IV Novel Approaches for Vaccine Delivery
Transcutaneous Immunization with Influenza Vaccines 347
Microneedle-Based Vaccines 369
Part V Vaccine Evaluation, Production and Distribution
Animal Models for Evaluation of Influenza Vaccines 397
Immunosenescence and Influenza Vaccine Efficacy 413
Vaccines for Pandemic Influenza: Summary of Recent Clinical Trials 431
Considerations for Licensure of Influenza Vaccines with Pandemic and Prepandemic Indications 453
Strategies for Broad Global Access to Pandemic Influenza Vaccines 471
Prioritization of Pandemic Influenza Vaccine: Rationale and Strategy for Decision Making 495
Index 509